Articles dans des revues avec comité de lecture (97)
  1. 49. Milenkovic, D., Vanden Berghe, W., Boby, C., Leroux, C., Declerck, K., Szarc vel Szic, K., Heyninck, K., Laukens, K., Bizet, M., Defrance, M., Dedeurwaerder, S., Calonne, E., Fuks, F., Haegeman, G., Haenen, G. R. M. M. G., Bast, A., & Weseler, A. R. (2014). Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state. PloS one, 9(4), e95527. doi:10.1371/journal.pone.0095527
  2. 50. Yan, W., Wu, K., Herman, J. G., Brock, M. M., Fuks, F., Yang, L., Zhu, H., Li, Y., Yang, Y., & Guo, M. (2013). Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer. Epigenetics, 8(12), 1373-1383. doi:10.4161/epi.26781
  3. 51. Delatte, B., & Fuks, F. (2013). TET proteins: On the frenetic hunt for new cytosine modifications. Briefings in Functional Genomics, 12(3), 191-204. doi:10.1093/bfgp/elt010
  4. 52. Deplus, R., Delatte, B., Schwinn, M. K., Defrance, M., Méndez, J., Murphy, N., Dawson, M. A., Volkmar, M., Putmans, P., Calonne, E., Shih, A. H., Levine, R. L., Bernard, O., Mercher, T., Solary, E., Urh, M., Daniels, D., & Fuks, F. (2013). TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO journal, 32(5), 645-655. doi:10.1038/emboj.2012.357
  5. 53. Dedeurwaerder, S., & Fuks, F. (2012). DNA methylation markers for breast cancer prognosis: Unmasking the immune component. Oncoimmunology, 1(6), 962-964. doi:10.4161/onci.19996
  6. 54. Guenin, S., Mouallif, M., Deplus, R., Lampe, X., Krusy, N., Calonne, E., Delbecque, K., Kridelka, F., Fuks, F., Ennaji, M. M., & Delvenne, P. O. (2012). Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis. PloS one, 7(8), e42704. doi:10.1371/journal.pone.0042704
  7. 55. Herzog, M., Josseaux, E., Dedeurwaerder, S., Calonne, E., Volkmar, M., & Fuks, F. (2012). The histone demethylase Kdm3a is essential to progression through differentiation. Nucleic acids research, 40(15), 7219-7232. doi:10.1093/nar/gks399
  8. 56. Volkmar, M., Dedeurwaerder, S., Andrade Da Cunha, D., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo Esteve, M., Naamane, N., Del Guerra, S., Masini, M., Bugliani, M., Marchetti, P., Cnop, M., Eizirik, D. L., & Fuks, F. (2012). DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO journal, 31(6), 1405-1426. doi:10.1038/emboj.2011.503
  9. 57. Dedeurwaerder, S., Desmedt, C., Calonne, E., Singhal, S. K., Haibe-Kains, B., Defrance, M., Michiels, S., Volkmar, M., Deplus, R., Luciani, J., Lallemand, F., Larsimont, D., Toussaint, J., Haussy, S., Rothé, F., Rouas, G., Metzger, O., Majjaj, S., Saini, K., Putmans, P., Hames, G., Van Baren, N., Coulie, P. G., Piccart-Gebhart, M., Sotiriou, C., & Fuks, F. (2011). DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO molecular medicine, 3(12), 726-741. doi:10.1002/emmm.201100801
  10. 58. Dedeurwaerder, S., Defrance, M., Calonne, E., Denis, H., Sotiriou, C., & Fuks, F. (2011). Evaluation of the Infinium Methylation 450K technology. Epigenomics, 3(6), 771-784. doi:10.2217/epi.11.105
  11. 59. Dedeurwaerder, S., Fumagalli, D., & Fuks, F. (2011). Unravelling the epigenomic dimension of breast cancers. Current opinion in oncology, 23(6), 559-565. doi:10.1097/CCO.0b013e32834bd481
  12. 60. Denis, H., Ndlovu, M. N., & Fuks, F. (2011). Regulation of mammalian DNA methyltransferases: A route to new mechanisms. EMBO reports, 12(7), 647-656. doi:10.1038/embor.2011.110
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>